By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regulus Therapeutics, Inc. 

1896 Rutherford Road

Carlsbad  California  92008-7208  U.S.A.
Phone: 888-734-8587 Fax: n/a


Start Up

Company News
Regulus Therapeutics, Inc. (RGLS) Gets Seat At Hepatitis C Table With Impressive Phase 1 Results; Stock Up 99.98% At 12:54PM ET On Wednesday 10/22/2014 8:22:52 AM
Regulus Therapeutics, Inc. Presents New Preclinical Data On Multiple Programs And Provides Portfolio Overview At 10th Annual Oligonucleotide Therapeutics Society (OTS) Meeting 10/14/2014 8:07:41 AM
Regulus Therapeutics, Inc. Announces Notice Of Allowance From U.S. Patent Office Related To Microrna-103/107 Program In Metabolic Disorders 9/24/2014 7:54:44 AM
Regulus Therapeutics, Inc. Initiates ATHENA Natural History Of Disease Study In Alport Syndrome Patients 9/18/2014 9:29:26 AM
Regulus Therapeutics, Inc. To Present At The Wedbush Life Sciences Management Access Conference 8/8/2014 8:33:03 AM
Regulus Therapeutics, Inc. Reports Second Quarter 2014 Financial Results And Recent Highlights 8/7/2014 8:41:37 AM
Regulus Therapeutics, Inc. Enters Into New Collaboration Agreement With Biogen Idec, Inc. (California) (BIIB) To Identify Microrna Biomarkers In Multiple Sclerosis 8/5/2014 6:39:41 AM
Regulus Therapeutics, Inc. Announces Timing For Second Quarter 2014 Financial Results Webcast And Conference Call 7/31/2014 8:26:03 AM
Regulus Therapeutics, Inc. Receives Orphan Drug Designation For RG-012, A microRNA Therapeutic For The Treatment Of Alport Syndrome 7/21/2014 12:17:12 PM
Regulus Therapeutics, Inc. Announces Patent Grant From U.S. Patent Office In Sarnow Patent Estate On Microrna Therapeutics For The Treatment Of HCV 6/25/2014 6:44:51 AM